Anthropic CEO says AI backlash stems from a crisis of trust

Anthropic CEO Dario Amodei has pushed back against criticisms that his warnings about artificial intelligence have fueled a public backlash against the industry. Responding to investor Gavin Baker, who argued on X and the All-In podcast that Amodei’s regulatory advocacy and warnings have harmed the sector, Amodei defended his public stance. He argued that his messaging has been balanced, pointing to his optimistic essay Machines of Loving Grace as evidence of his efforts to paint an inspiring future for the technology.

According to Amodei, the widespread skepticism surrounding AI is not the result of executive warnings but is "fundamentally a crisis of trust" in corporations and governments. He noted that the industry has yet to deliver on its grandest promises, such as curing cancer, which remains more of a cliché than a reality. For AI practitioners, this highlights a growing gap between corporate marketing and tangible, real-world benefits, suggesting that building public confidence will require delivering concrete results rather than simply adjusting promotional messaging.

The debate also touched on the regulatory landscape, including a California bill that imposes transparency requirements on large AI companies. Amodei rejected the idea that regulation inevitably leads to regulatory capture or a concentration of power. Instead, he stated that Anthropic carefully designs its policy proposals to slow down frontier AI developers while advantaging smaller competitors. He warned that AI structurally tends to concentrate power, and that open-weights models are not a complete solution because they ultimately shift control to entities with the most compute and chips.

For developers and researchers, Amodei's comments signal that the regulatory debate is shifting from a simple pro- or anti-regulation binary to a more nuanced discussion on structural power. Practitioners working with open-weights models must navigate a landscape where compute access remains the ultimate bottleneck, while those at frontier labs can expect continued pressure to justify their safety frameworks and deliver immediate, practical value to the public.